Acceptability of Extended-Release Naltrexone by Heroin-Dependent Patients and Addiction Treatment Providers in the Netherlands

References

• Abraham, A. J., & Roman, P. M. (2010). Early adoption of injectable naltrexone for alcohol-use disorders: Findings in the private-treatment sector. Journal of Studies on Alcohol and Drugs, 71, 460–466.
   Google Scholar
• Blanken, P., van den Brink, W., Hendriks, V. M., Huijsman, I. A., Klous, M. G., Rook, E. J., … van Ree, J. M. (2010). Heroin-assisted treatment in the Netherlands: History, findings, and international context. European Neuropsychopharmacol, 20(Suppl. 2), S105–S158. doi:10.1016/S0924-977X(10)70001-8
   Google Scholar
• Collins, S. E., Duncan, M. H., Smart, B. F., Saxon, A. J., Malone, D. K., Jackson, T. R., & Ries, R. K. (2015). Extended-release naltrexone and harm reduction counseling for chronically homeless people with alcohol dependence. Substance Abuse, 36, 21–33. doi:10.1080/08897077.2014.904838
   Google Scholar
• Cruts, G., van Laar, M., & Buster, M. (2013). Aantal en kenmerken van problematische opiatengebruikers in Nederland. Utrecht, The Netherlands: Trimbos instituut (Netherlands Institute of Mental Health and Addiction).
   Google Scholar
• Degenhardt, L., Whiteford, H., & Hall, W. D. (2014). The Global Burden of Disease projects: What have we learned about illicit drug use and dependence and their contribution to the global burden of disease? Drug and Alcohol Review, 33(1), 4–12. doi:10.1111/dar.12088
   Google Scholar
• Fishman, M. J., Winstanley, E. L., Curran, E., Garrett, S., & Subramaniam, G. (2010). Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case-series and feasibility. Addiction, 105(9), 1669–1676. doi:10.1111/j.1360-0443.2010.03015.x
   Google Scholar
• Friedmann, P. D., Mello, D., Lonergan, S., Bourgault, C., & O'Toole, T. P. (2013). Aversion to injection limits acceptability of extended-release naltrexone among homeless, alcohol-dependent patients. Substance Abuse, 34(2), 94–96. doi:10.1080/08897077.2012.763083
   Google Scholar
• Gastfriend, D. R. (2011). Intramuscular extended-release naltrexone: current evidence. Annals of the New York Academy of Sciences, 1216, 144–166. doi:10.1111/j.1749-6632.2010.05900.x
   Google Scholar
• Gonzalez, J. P., & Brogden, R. N. (1988). Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs, 35, 192–213.
   Google Scholar
• Hall, W., Doran, C., Degenhardt, L., & Shepard D. (2006). Illicit opiate abuse. In D. T. Jamison, J. G. Breman, A. R. Measham, G. Alleyne, M. Claeson, D. B. Evans, P. Jha, A. Mills, & P. Musgrove (Eds.), Disease control priorities in developing countries (2nd ed., pp. 77–100). Washington, DC: World Bank.
   Google Scholar
• Krupitsky, E., Nunes, E. V., Ling, W., Illeperuma, A., Gastfriend, D. R., & Silverman, B. L. (2011). Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial. Lancet, 377(9776), 1506–1513. doi:10.1016/S0140-6736(11)60358-9
   Google Scholar
• Krupitsky, E., Zvartau, E., Blokhina, E., Verbitskaya, E., Wahlgren, V., Tsoy-Podosenin, M., … Woody, G. E. (2012). Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence. Archives of General Psychiatry, 69(9), 973–981.
   Google Scholar
• Lobmaier, P., Kornor, H., Kunoe, N., & Bjørndal, A. (2008). Sustained-release naltrexone for opioid dependence. Cochrane Database of Systematic of Review, 16, CD006140.
   Google Scholar
• Lobmaier, P. P., Kunøe, N., Gossop, M., & Waal, H. (2011). Naltrexone depot formulations for opioid and alcohol dependence: A systematic review. CNS Neuroscience & Therapeutics, 17(6), 629–636. doi:10.1111/j.1755-5949.2010.00194.x
   Google Scholar
• McKeganey, N., Bloor, M., Robertson, M., Neale, J., & MacDougall, J. (2006). Abstinence and drug abuse treatment: Results from the drug outcome research in Scotland study. Drugs-Education Prevention & Policy, 13(6), 537–550. doi:10.1080/09687630600871987
   Google Scholar
• McKeganey, N., Morris, Z., Neale, J., & Robertson, M. (2004). What are drug users looking for when they contact drug services: abstinence or harm reduction? Drug-Education Prevention & Policy, 11(5), 423–435. doi:10.1080/09687630410001723229
   Google Scholar
• McLellan, A. T., Luborsky, L., Woody, G. E., & O'Brien, C. P. (1980). An improved diagnostic evaluation instrument for substance abuse patients. The addiction severity index. Journal of Nervous and Mental Disease, 168, 26–33. doi:10.1097/00005053-198001000-00006
   Google Scholar
• Minozzi, S., Amato, L., Bellisario, C., & Davoli, M. (2011). Detoxification treatments for opiate dependent adolescents (Review). Cochrane Database of Systemic Review, 4, CD006749.
   Google Scholar
• Neale, J. (1998). Drug users' views of prescribed methadone. Drug-Education Prevention & Policy, 5(1), 33–45.
   Google Scholar
• Neale, J., Nettleton, S., & Pickering, L. (2013). Does recovery-oriented treatment prompt heroin users prematurely into detoxification and abstinence programmes? Qualitative study. Drug & Alcohol Dependence, 127(1–3), 163–169. doi:10.1016/j.drugalcdep.2012.06.030
   Google Scholar
• Schippers, G. M., Broekman, T. G., Buchholz, A., Koeter, M. W. J., & van den Brink, W. (2010). Measurements in the addictions for triage and evaluation (MATE): An instrument based on the world health organization family of international classifications. Addiction, 105(5), 862–871. doi:10.1111/j.1360-0443.2009.02889.x
   Google Scholar
• Syed, Y. Y., & Keating, G. M. (2013). Extended-release intramuscular naltrexone (VIVITROL®): A review of its use in the prevention of relapse to opioid dependence in detoxified patients. CNS Drugs, 27(10), 851–861. doi:10.1007/s40263-013-0110-x
   Google Scholar
• van den Brink, W., Hendriks, V. M., Blanken, P., Koeter, M. W. J., van Zwieten, B. J., & van Ree, J. M. (2003). Medical prescription of heroin to treatment resistant heroin addicts: Two randomised controlled trials. BMJ, 327, 1–6.
   Google Scholar
• Wisselink, D. J., Kuijpers, W. G. T., & Mol, A. (2013). Kerncijfers Verslavingszorg 2012 Landelijk Alcohol en Drugs Informatie Systeem (LADIS). Houten, The Netherlands: Stichting Informatie Voorziening Zorg.
   Google Scholar
• Wisselink, D. J., Kuijpers, W. G. T., & Mol, A. (2014). Kerncijfers Verslavingszorg 2013 Landelijk Alcohol en Drugs Informatie Systeem (LADIS). Houten, The Netherlands: Stichting Informatie Voorziening Zorg.
   Google Scholar